ReedGroup®’s Proprietary MDGuidelines® Population Database Grows to More Than 15 Million Cases
Expanded big data resource helps healthcare providers and payers improve health and financial outcomes
The MDGuidelines Population Database now includes more than 15 million real-world illness and injury case claims, allowing clinical and business leaders to measure how their patient populations compare against broader population benchmarks. The Population Database also serves as a source for advanced analytics, delivering highly personalized and accurate estimates of the amount of time it takes for an individual to return to activity after illness or injury. (All data is used on the aggregate level and no individual data or information is ever shared.)
With its increase to more than 15 million records, MDGuidelines now offers the richest diversification of disability case data in the industry, providing analytics and insights based on medical code, length of disability, comorbidities, age, gender, industry code, program type and healthcare costs. This robust set of data enables clinicians to be more precise in predicting return to activity outcomes and empowers business leaders with data to identify areas of opportunity to improve care and reduce costs.
“Our customers rely on MDGuidelines to help improve health and financial outcomes for their employee and patient populations,” said
The Population Database serves as the foundation of ReedGroup’s complete clinical decision support solution, MDGuidelines, which combines clinical practice guidelines, disability durations estimates, a drug formulary, predictive analytics, and other tools into an integrated solution for case managers and clinicians.
Containing both short-term disability and worker’s compensation cases, the MDGuidelines Population Database has been in production since 2005, and is managed by ReedGroup’s team of data scientists, epidemiologists, data architects, and biostatisticians. The data warehouse contains more than 12,000 unique healthcare diagnoses.
About ReedGroup
ReedGroup, a wholly owned subsidiary of
About MDGuidelines
ReedGroup’s flagship product, MDGuidelines, is the industry’s leading solution for total health management and workplace productivity. MDGuidelines features the world’s most trusted disability duration estimates and evidence-based Practice Guidelines from
View source version on businesswire.com: https://www.businesswire.com/news/home/20180404005436/en/
Media Contact:
ReedGroup
[email protected]
Source: ReedGroup
Clinical Decision Support Systems Market – Global Forecasts to 2023
Ketamine, notorious club drug, shows great promise as a treatment for depression, clinic operators say
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News